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Evaluation of phagocytic cell function in an ex vivo model of hemodi-
alysis. An ex vivo model of hemodialysis was used to evaluate the effect
of dialysis membranes on phagocytic cell function. Blood was with-
drawn continuously from healthy, non-uremic donors, heparinized, and
pumped, single pass, through membrane modules under conditions
which simulated normal dialysis conditions. The membrane modules
contained membranes of cellulose, DEAE-substituted cellulose, or
polysulfone. Blood was obtained from the module outlets for determi-
nation of complement activation, phagocyte elastase release, zymosan-
induced phagocyte chemiluminescence, and monocyte interleukin-l
production, Significantly less complement activation occurred with the
polysulfone and DEAE-substituted cellulose membranes than with
cellulose membranes. Normal monocyte interleukin-l production was
not stimulated by any of the membranes used. En contrast, the cellulo-
sic, but not the polysulfone, membranes primed the oxidative burst of
the phagocytes and caused them to release elastase. DEAE-substituted
cellulose had a lesser effect on elastase release than did cellulose and
elastase release correlated significantly with the degree of complement
activation. However, the correlation between complement activation
and priming of phagocyte oxidative burst was weak, suggesting that
membranes affect phagocyte oxidative metabolism through more than
one mechanism. We conclude that some dialysis membranes stimulate
the bacteriacidal functions of normal phagocytic cells, in part through
complement-dependent mechanisms.
Phagocytic cells play an important role in the host defense
against microbial invasion. Neutrophils and monocytes ingest
bacteria and subsequently kill them primarily through the
generation of oxygen radicals (the oxidative burst). In addition,
monocytes release interleukin-l (IL-i), a key signal in the acute
phase response to microbial invasion. Disruption of phagocyte
function poses a threat to the host. Down-regulation of phago-
cytes may increase susceptibility to infection, while up-regula-
tion may lead to tissue damage by released oxygen radicals and
lysosomal enzymes or initiation of some acute phase response
reactions by release of IL-I.
The extent to which phagocytes are affected by hemodialysis,
and the consequences, is the subject of considerable debate.
The ability of neutrophils in dialyzer effluent blood to generate
oxygen radicals has been reported to be both depressed [11 and
unchanged (21, while others 131 have hypothesized that passage
of blood through a dialyzer can lead to monocyte stimulation
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and release of IL-i. Further, in vitro studies have shown that
the nature of the dialysis membrane influences the production
of both oxygen radicals [4, 5] and IL-i [6].
Elucidation of the effect of the dialysis membrane on phago-
cytic cell function is complicated by a number of factors. First,
uremia may modify phagocytes so as to either enhance or blunt
their response to stimulation. Although IL-i secretion by mono-
cytes from uremic subjects is reported to be normal [7],
neutrophils from uremic subjects have been reported to be
primed to release increased amounts of oxygen radicals in
response to a stimulus [8, 9]. Second, other aspects of the
dialysis procedure, such as the presence of endotoxin in the
dialysate [10], may play a role in phagocyte stimulation. Third,
because dialysis is a closed-loop system, cells previously ex-
posed to the membrane, as well as activated plasma compo-
nents, return to the patient and may influence subsequent
events. Finally, in vitro systems often do not simulate the fluid
dynamics of dialysis and events that occur in vitro may require
contact times in excess of those which exist in clinical dialysis.
We used an cx vivo model of hemodialysis, which largely
eliminates these complicating factors, to answer the question
whether or not exposure to the dialysis membrane, per Se,
affects phagocytic cell function.
Methods
Membrane modules
Three membrane materials were studied, cellulose (Cu-
prophan, AKZO, Wuppertal, FRG) (CU), cellulose in which
less than 1% of the hydroxyl groups were replaced by N,
N-diethyl-aminoethyl groups (Hemophan, AKZO, Wuppertal,
FRG) (DEAE-CU), and polysulfone (Amicon, Lexington, Mas-
sachusetts, USA) (PS). The membranes were obtained in hol-
low fiber form, potted in polyurethane, and housed in polycar-
bonate modules. Each module contained 250 cm2 of membrane.
The modules were sized to simulate the conditions of clinical
dialysis (blood flow rate 200 ml/min, dialysate flow rate 500
mI/mm, membrane area 1 m2) when used with a blood flow rate
of 5 mI/mm and a dialysate flow rate of 12 mI/mm.
The modules were sterilized with ethylene oxide and allowed
to outgas for at least seven days. On the day prior to the
experiment, the silicone rubber tubing set (Rehau AG, Rehau,
FRG) was rinsed sequentially with 1 M sodium hydroxide, 1 M
hydrochloric acid, and sterile, pyrogen-free water. The modules
were then connected to the tubing set, filled with 10% isopro-
panol, and allowed to stand overnight. On the day of the
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Fig. 1. Schematic representation of the ex
vivo model system.
experiment, the modules were rinsed with 1 liter of sterile,
pyrogen-free saline. A 1 ml aliquot of saline was collected from
the outlet of the module at the end of the rinse period and tested
for the presence of 'iacterial endotoxin. Any module testing
positive for bacterial endotoxin was discarded.
Experimental protocol
The effect of the different membrane materials on phagocytic
cells was evaluated using a modification of an ex vivo perfusion
system which has been described previously [11, 12]. The
system is shown schematically in Figure 1. Briefly, two mem-
brane modules and a tubing control were perfused, in parallel,
with blood from a healthy donor at a rate of 5 mLtmin for 30
minutes. The blood was obtained from an antecubital vein using
a specially designed catheter which allows the blood to be
heparinized (0.5 lU/mI) immediately as it enters the catheter tip.
Blood flow was maintained using a multichannel peristaltic
pump (Ismatec, Zurich, Switzerland) and flow rates were
checked periodically throughout the experiment by timed col-
lection at the outlet of each channel. The dialysate side of each
module was perfused at a rate of 12 mI/mm with standard
acetate-containing dialysate maintained at 37°C. A module with
CU membranes was included in each experiment; the second
module contained membranes of either DEAE-CU or PS.
After catheter insertion, 3 ml of blood was withdrawn and
discarded to clear any plasma or tissue components activated
during venipuncture. Baseline blood samples (Pre) were then
drawn for determination of white blood cell count and differen-
tial, monocyte IL-1$ production, zymosan-induced phagocyte
oxygen radical production, and plasma concentrations of C3a
des Arg, C5a des Arg and elastase-a1-antitrypsin complex. The
catheter was next connected to the tubing set and perfusion
commenced. Blood samples were obtained from the outlets of
the modules and the tubing control throughout the experiment
for determination of zymosan-induced phagocyte oxygen radi-
cal production (15 and 30 mm) and plasma concentrations of
C3a des Arg, C5a des Arg and elastase-a1-antitrypsin complex
(5, 10, 15, 20, 25, and 30 mm). All other blood leaving the
modules and tubing control was collected in sterile, pyrogen-
free containers for mononuclear cell isolation and determina-
tion of monocyte IL-lf3 production.
A total of 16 donors, including both males and females, were
studied. The donors ranged in age from 21 to 39 years and all
had been free of infection for at least one week at the time of
study; none was known to be taking anti-inflammatory drugs or
antibiotics.
Analytical methods
Priming of phagocyte oxygen radical production was as-
sessed by measuring the luminol-enhanced chemiluminescence
released during incubation of whole blood with opsonized
zymosan [131. Immediately after collection, blood samples were
diluted with phosphate-buffered saline, mixed well, and placed
on ice. The chemiluminescence assay was performed within 30
minutes of obtaining the blood sample. An aliquot of the diluted
blood was added to veronal buffer supplemented with luminol
(final blood dilution 1:300, final luminol concentration 70 M)
and incubated at 37°C for five minutes. Opsonized zymosan
(final concentration 1.0 mg/mi) was then added, the sample
placed in a dark-adapted vial, and the resulting light emission
measured using a Biolumat LB 9505 luminometer (Berthold,
Wildbad, FRG). Emitted light was collected for 20 minutes and
the counts normalized by the number of phagocytes (neutro-
phils + monocytes) in the sample.
To determine monocyte IL-I 3 production, mononuclear cells
were isolated from the heparinized blood by density gradient
centrifugation over Ficoll-Hypaque (Pharmacia, Upsala, Swe-
den). Interfacial cells were collected, washed with RPMI 1640
(Biochrom, Berlin, FRG) containing 2.5% fetal calf serum, and
stored in liquid nitrogen in the presence of 10% dimethylsulfox-
ide and 20% fetal call serum until being assayed. The ability of
the monocytes to produce IL-1f3 spontaneously was determined
as described previously [14]. Mononuclear cells (3 x 106
cells/mi) were resuspended in endotoxin-free RPMI 1640 media
Heparin
5 U/mI, 1.5 mi/mm
12 mi/mit,
5 mI/mm
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Fig. 2. Plasna C3a des Arg concentrations as a function of perfusion
time. Pre data represent plasma obtained immediately following cathe-
ter insertion, while data at all other time points represent plasma
obtained from the outlets of the membrane modules, Symbols represent
modules containing CU (N = 16; *), DEAE-CU (N = 8; ), PS (N = 8;
•), and the tubing control (N = 16; A). Statistical differences between
different membrane modules are iescribed in the text.
supplemented with penicillin (500 lU/mi), streptomycin (500
/LgImi; Gibco, Paisley, Scotland, UK) and 2% heat-inactivated
human serum. Adherence purification was not used in these
experiments in order to avoid differential loss of monocytes.
Monocytes were enumerated by staining with fluorescein-
conjugated anti-LeuM3 monoclonal antibody (Becton Dickin-
son, Mountain View, California, USA) and analysis with a
fluorescence-activated cell sorter (EPICS V, Coulter Electron-
ics, Krefeld, FRG). The cells were incubated in 24-well culture
plates in a 5% CO2 atmosphere for 17 hours at 37° C. The cells
were then lysed by repeated freezing and thawing and the
resulting supernatants assayed for total IL-1f3 (extracellular +
cell-associated) by radioimmunoassay (Cistron, Pine Brooks,
New Jersey, USA). IL-i data were corrected for the number of
monocytes in the sample using the formula ng/ml x 100 divided
by the percentage of LeuM3 + cells.
Plasma concentrations of the complement fragments, C3a des
Arg and C5a des Arg, were determined by radioimmunoassay
(Amersham Buchler GmbH, Braunschweig, FRG). Plasma con-
centrations of leukocyte elastase were measured as the
elastase-a1-antitrypsin complex by an enzyme-linked immuno-
sorbent assay (E. Merck, Darmstadt, FRG). Total leukocyte
counts were made using a model CC- 130 micro cell counter
(Sysmex, TOA Medical Electronics, Kobe, Japan). The leuko-
cyte differential was obtained by hand-counting 200 cells in
May-Grunwald and Giemsa stained smears. Bacterial endo-
toxin concentrations were determined using a commercially
available Limulus amebocyte lysate (LAL) assay kit (BYK-
Mallinckrodt, Dietzenbach, FRG) which had a sensitivity of 10
pg/mi for LPS from E. coli 055:B5.
Statistical methods
The data are presented as mean standard error of the mean.
The effects of perfusion time and the three membrane materials
on the measured parameters were compared by a two-way
analysis of variance. The method of least significant differences
Pre 0 5 10 15 20 25 30
Perfusion time. minutes
FIg. 3. Plasma C5a des Arg concentrations as a function of perfusion
time. Pre data represent plasma obtained immediately following cathe-
ter insertion, while data at all other time points represent plasma
obtained from the outlets of the membrane modules. Symbols represent
modules containing CU (N = 16; *), DEAE-CU (N = 8; •), PS (N = 8;
•), and the tubing control (N = 16; A). Statistical differences between
different membrane modules are described in the text.
was used to test differences between individual groups when the
F value indicated that significant differences existed.
Results
The response of plasma C3a des Arg concentrations to
perfusion through the membrane modules is shown in Figure 2.
The concentration of C3a des Arg increased with time in the
effluent blood from the CU modules, reaching a peak after 15
minutes. Thereafter, the concentration decreased, but was still
significantly increased above the arterial value at 30 minutes.
The effluent C3a des Arg concentration also increased signifi-
cantly with the DEAE-CU modules. However, the peak con-
centrations between 10 and 20 minutes were significantly less
than those observed with CU modules. In contrast, C3a des Arg
concentrations remained unchanged from arterial levels in the
effluent blood from the PS modules and the tubing control. The
concentrations of C3a des Arg in the effluent blood from the PS
modules and the tubing controls were significantly less than
those observed for CU and DEAE-CU at all sample times after
five minutes, apart from 10 and 25 minutes when the effect of
the PS modules on C3a des Arg could not be statistically
separated from that of the DEAE-CU modules.
Effluent CSa des Arg concentrations from the CU modules
showed a similar pattern to that observed for C3a des Arg,
although the peak concentration was not seen until 20 minutes
(Fig. 3). However, in contrast to C3a des Arg, C5a des Arg
concentrations remained unchanged with the DEAE-CU mod-
ules. Again, neither the PS module nor the tubing control
caused C5a des Arg concentrations to increase. The response
for the CU modules was significantly different from that ob-
served for all other modules and the tubing control at all
sampling times after five minutes.
Concentrations of the elastase-a1-antitrypsin complex pro-
gressively increased in the effluent blood from the CU modules
and were significantly greater than arterial values at all sampling
times after 10 minutes (Fig. 4). Elastase-a1-antitrypsin concen-
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Fig. 4. Plasma elastase-a1-antit,ypsin concentrations as a function of
perfusion time. Pre data represent plasma obtained immediately follow-
ing catheter insertion, while data at all other time points represent
plasma obtained from the outlets of the membrane modules. Symbols
represent modules containing CU (N = 16;*, DEAE-CU (N = 8; U), PS(N = 8; •), and the tubing control (N = 16; A). Statistical differences
between different membrane modules are described in the text.
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Fig. 6. Phagocytic cell chemiluminescence following stimulation with
opsonized zymosan. Pre data represent phagocytes obtained immedi-
ately following catheter insertion, while data at 15 and 30 minutes of
perfusion represent phagocytes obtained from the outlets of the mem-
brane modules. Bars represent modules containing CU (U), DEAE-CU
(EJ), polysulfone (), and the tubing control (a). Statisticaldifferences
between different membrane modules are described in the text.
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Fig. 5. Generation of elastase-a1-antitrypsin as a function of C3a des
Arg generation for a typical experiment. Symbols represent modules
containing Cu (*), polysulfone (•), and the tubing control (A).
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trations remained unchanged from arterial values in the ef-
fluents from the DEAE-CU and PS modules and the tubing
control. CU was associated with significantly greater effluent
elastase-a1-antitrypsin concentrations than the other modules
and the tubing control at all sampling times after 10 minutes,
with two exceptions. The response to CU could not be differ-
entiated from the response to PS at 25 minutes or the response
to DEAE-CU at 30 minutes.
Although the magnitude of the response varied widely from
donor to donor, there was a significant correlation between
generation of the elastase-a1-antitrypsin complex and the gen-
eration of C3a des Arg. A typical set of data is shown in Figure
5 for an experiment involving CU and PS modules.
Fig. 7. Interleukin-! concentrations in supernatants from lysed mono-
cytes following incubation for 17 hours at 37°C.
a1-antitrypsin complex, there was only a weak association
between C3a des Arg generation and the increase in zymosan-
stimulated chemiluminescence across the membrane modules,
which reached significance only when all data were considered
together (r 0.357, N = 93, P < 0.001).
Exposure to the membrane modules did not result in any
change in the spontaneous generation of IL-1/3 by peripheral
blood mononuclear cells (Fig. 7). The viability of the cells was
investigated by determining their ability to produce IL-lf3 in
response to lipopolysacchande. Total supernatant IL-l/3 con-
centration was 24.2 3.3 ng/ml (N = 5) following incubation
with 20 jzg/ml lipopolysaccharide (E. coli 055:B5, Sigma, St.
Louis, Missouri, USA) compared with 0.25 ng/ml for non-
stimulated cells.
Discussion
It has been suggested that phagocytic cells may be function-
ally affected by hemodialysis, leading to a variety of adverse
consequences for the patient. The recently developed "Inter-
Zymosan-stimulated phagocyte chemiluminescence was in-
creased over arterial levels in the effluent blood from all
modules and the tubing control (Fig. 6), indicating priming of
the oxidative burst. The extent of priming with CU and DEAE-
CU modules was significantly greater than with the PS modules
and the tubing control. Unlike generation of the elastase-
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leukin Hypothesis" proposes that monocytes become activated
during dialysis, leading to the release of the monokine, IL-i [31.
Others have suggested that neutrophils may also be affected,
possibly leading to tissue damage by released oxygen radicals
[15] or an impaired ability to respond to microbial invasion
because of down-regulation of cell receptors [16]. The role of
the dialyzer membrane in such cell stimulation remains contro-
versial.
Our data show that passage of a normal monocyte through
dialyzers containing either cellulosic or synthetic PS mem-
branes is insufficient to stimulate IL-1/3 production (Fig. 7).
Previously, cellulosic and polyacrylonitrile membranes have
been reported to increase monocyte IL-i production in vitro [6,
7, 17] and serum IL-i and monocyte IL-i production have been
reported to increase during dialysis with dialyzers containing
cellulosic membranes [7, 18]. Incubation times of greater than
one hour are required to achieve an increase in IL-i production
in vitro [17]. These incubation times contrast with a transit time
of cells through the membrane modules of 20 seconds in the ex
vivo system, and this difference most likely explains the differ-
ence between our results and those obtained in vitro. The
situation in routine hemodialysis is more complex. Although
transit times for cells through a dialyzer in routine hemodialysis
are in the range of 15 to 30 seconds, the cells may cycle through
the dialyzer multiple times. Indeed, increase" in cell-associated
IL-i activity have been shown after five hours of dialysis with
dialyzers containing Cuprophan membranes [7, 18], suggesting
that there may be sufficient exposure of monocytes to the
membrane over the course of an entire treatment to stimulate
IL-i production. However, other factors may also play a role.
Studies have shown that substances derived from the dialysate,
such as endotoxin or endotoxin fragments [19, 20] and acetate
[21], can stimulate IL-i production, independently of the dia-
lyzer membrane. We took great care to exclude endotoxin from
our membrane modules and the dialysate. In addition, Bingel et
al [191 have shown that IL-l production is not stimulated during
in vitro dialysis with cellulosic membranes except when the
dialysate contains endotoxin, More detailed kinetic studies, in
which care is taken to avoid microbiological contamination of
the dialysate, will be required to resolve the issue of whether or
not there is a direct role for the diaiyzer membrane in the
"Interleukin Hypothesis", apart from the extent to which it
may allow endotoxin transfer from the dialysate to the blood.
In contrast to finding no effect on monocyte IL-l/3 produc-
tion, we found that neutrophils may become stimulated during
a single pass through a dialyzer, depending on the membrane
material (Figs. 4, 6). Neutrophil activation is demonstrated by
the increase in plasma elastase and priming of the oxidative
burst seen with the CU and, to a lesser extent, the DEAE-CU
membranes (Figs. 4, 6). Schaefer et al have previously shown
that plasma elastase increases during hemodialysis, the increase
being more marked with dialyzers containing CU membranes
than with dialyzers containing PS membranes [22] or DEAE-
CU membranes [23]. Activation of neutrophils by single pas-
sage through a dialyzer containing CU membranes is also
suggested by reports documenting an increased expression of
the complement receptor, CR3 [2, 24].
Previous data on the effect of dialyzers on the oxidative burst
of neutrophils are conflicting. A number of studies have used
chemiluminescence assays to examine changes in the oxidative
burst during dialysis with dialyzers containing cellulosic mem-
branes. Neutrophil chemiluminescence following stimulation
with various agents has been reported to be decreased com-
pared to pre-dialysis values during the first 30 minutes of
dialysis [25—28]. However, these studies examined cells from
blood entering the dialyzer and, therefore, the results may not
accurately reflect the effect of membrane exposure on priming
of the neutrophil oxidative burst. CU membranes are associated
with a complement mediated pulmonary sequestration of leu-
kocytes during the first hour of dialysis [29]. Neutrophils
activated during passage through the dialyzer may be seques-
tered in the pulmonary vasculature on their return to the
circulation, leading to an increase in the proportion of function-
ally effete cells in the circulation [26, 30] and a reduced
chemiluminescent response. Recent studies [1, 2] have exam-
ined oxidative metabolism in neutrophils drawn simultaneously
from the inlet and outlet blood of dialyzers containing CU
membranes after 15 minutes of dialysis. In contrast to our
results, these studies found a decrease [1] or no change [2] in
stimulated oxygen radical production following passage of the
neutrophils through the dialyzer. This apparent lack of a
priming effect by the membrane in vivo may reflect a decrease
in the proportion of functionally competent cells in the circula-
tion secondary to pulmonary sequestration [26, 30]. Indeed,
Markert et al [28] showed that stimulated oxygen radical
production was increased after five minutes of dialysis, when
neutropenia was less well developed. Alternatively, failure to
see priming of the neutrophil oxidative burst following passage
through the dialyzer in vivo may reflect alterations in neutrophil
function associated with uremia or chronic hemodialysis. Neu-
trophils obtained from chronic hemodialysis patients at the
beginning of a treatment have been reported to manifest an
enhanced [2, 8, 9], normal [31], or depressed [4, 32, 33]
oxidative burst following stimulation with various agents. In
addition, Lewis et al have shown neutrophils from hemodialysis
patients to have a decreased C5a receptor availability [34] and
a reduced chemotactic response [35], Thus, the complex inter-
actions associated with uremia and dialysis may serve to mask
the stimulatory effect of some dialysis membranes on neutrophil
oxidative burst seen in our studies.
Previous studies have shown that CSa can cause neutrophils
to degranulate [36] and prime their oxidative burst [37, 38] and
a relationship between complement activation and stimulation
of neutrophils has been suggested by the results of in vitro
studies [5]. Our data show a correlation between the appear-
ance of elastase and complement activation (Fig. 5), but only a
weak association between priming of the oxidative burst and
complement activation. Most notably, the oxidative burst fol-
lowing exposure to DEAE-CU was similar to that observed for
CU (Fig. 6) in spite of a significantly lesser degree of comple-
ment activation (Figs. 2, 3). These data suggest that, while
complement activation may be one mechanism through which
membranes stimulate neutrophil function, other mechanisms,
such as a direct cell-membrane interaction (frustrated phagocy-
tosis) may also occur. This is supported by the data of Betz et
al [17], who found an increase in superoxide production follow-
ing exposure of neutrophils to CU in the absence of comple-
ment, and Horl et al [39], who found increased concentrations
of elastase during dialysis with dialyzers containing polymeth-
ylmethacrylate membranes which are known not to activate
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complement [40]. Further studies will be required to determine
which mechanisms dominate in the activation of neutrophils by
dialysis membranes.
Some caution should be exercised in extending our findings to
clinical hemodialysis. We have shown that dialysis membranes
affect normal phagocytic cells under conditions similar to those
found during hemodialysis. Membranes based on cellulose
enhanced phagocyte bacteriacidal functions as demonstrated by
priming of the oxidative burst and the release of lysosomal
enzymes. Further, our data suggest that these effects are, at
least in part, the result of complement activation. However,
whether or not uremic cells respond in the same manner
remains to be conclusively demonstrated. Neither cellulosic or
polysulfone membranes stimulated monocytes to produce the
regulatory cytokine, interleukin-l, following single-pass expo-
sure to the membranes. This observation may indicate that
stimulation of phagocytic cells by membranes does not extend
to all cellular functions. Alternatively, the kinetics of stimula-
tion may require repeated exposure of the cells to the mem-
brane as occurs in hemodialysis. Whether or not membranes
have a direct affect on monocyte cytokine release in hemodial-
ysis remains controversial. However, if extended exposure
times are required, the ex vivo model will be of limited use in
studying this aspect of membrane biocompatibility.
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